Consultants

Germany Consultants

European Consultants

US Consultants

Olympic Therapeutics Inc., USA, (MycoGenyx Inc., Seattle) Director Dr. Warren Wheeler, Director Dr. Richard Honour, Microbiology and Virology

are working intensively on finalizing further prepared intellectual property for several phages against MRSA and MSSA, VAP, and other deadly infections and respiratory infections; in particular, hospital-acquired killers.

Olympic Therapeutics AG, Switzerland, is cooperating with an investor group based in Lower Austria for private fund financing for clinical trials (phases I and II) and for IP patenting of the most important bacteriophages against multi-resistant bacteria: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. One of the most dangerous hospital germs (killer germs) is Staphylococcus aureus (MRSA)! Another increasingly prevalent hospital germ (killer germ) is Acinetobacter baumannii…

The investor group based in Lower Austria is also planning to build a specialized clinic (hospital project including a hotel) for the treatment of MRSA patients in the greater Wiener Neustadt-Burgenland/Neusiedler See area.